Originally published on Trial Site News.
On August 23, 2021, the US Food and Drug Administration (FDA) granted approval (or licensure) to the first ever COVID-19 mRNA gene therapy product by Pfizer/Bi…
Keep reading with a 7-day free trial
Subscribe to Sonia Elijah investigates to keep reading this post and get 7 days of free access to the full post archives.